PulsENDO for diabetes and fatty liver
Part of Hormones & metabolism clinical trials.
This trial tests a new endoscopic procedure (pulsENDO) for people with type 2 diabetes and fatty liver disease whose blood sugar remains high despite taking diabetes pills. It aims to see if this treatment can improve blood sugar control and liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had type 2 diabetes for less than 10 years.
- Your body mass index (BMI) is between 18.5 and 40.
- Your blood sugar is not well controlled (HbA1c between 7.5% and 11%) even though you are taking diabetes pills.
- You are not using insulin.
- You have not had stomach or bowel surgery, and you do not have active ulcers or bleeding in your stomach or duodenum.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study checks how a new tablet moves through the body and if it is safe for people with mild or moderate liver problems compared to people with healthy livers. It might help doctors understand how to dose the drug for people like you.
This study tests a new procedure called pulsENDO, which is done in the first part of the small intestine (the duodenum) to help treat type 2 diabetes. It may be an option for people who were recently diagnosed and have good blood sugar control with little or no diabetes medication.
This trial tests a procedure that reshapes the stomach and treats the upper intestine to help control blood sugar and weight in people with obesity and type 2 diabetes. It may be an option if you have a moderate to high need for metabolic surgery.
This study tests a procedure called pulsENDO that uses pulses of energy in the upper intestine to improve blood sugar control in people with type 2 diabetes. It might help you manage your diabetes better.
This trial studies whether an endoscopic (camera-guided) stomach tightening/suturing procedure plus standard diabetes care can improve health in people with type 2 diabetes and mild-to-moderate obesity. It compares this procedure to standard care alone to see which approach works better and is safe.
This trial tests a new procedure called pulse electric field ablation to see if it can help people with type 2 diabetes whose blood sugar is not well controlled by oral medications. The procedure uses a small device passed through the mouth to the upper intestine.
Hear when a new Metabolic Syndrome (MetS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.